|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.58 CNY | -1.22% |
|
-5.25% | -19.36% |
| 05-25 | Mayinglong Pharmaceutical Gets Regulatory Approval for Eye Drops | MT |
| 04-24 | Mayinglong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 9.73B 1.44B 1.26B 1.16B 1.09B 2.04B 136B 2.05B 13.8B 5.34B 66.83B 5.4B 5.28B 232B | P/E 2026 * |
14.5x | P/E 2027 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 9.73B 1.44B 1.26B 1.16B 1.09B 2.04B 136B 2.05B 13.8B 5.34B 66.83B 5.4B 5.28B 232B | EV / Sales 2026 * |
2.25x | EV / Sales 2027 * | 2.05x |
| Free-Float |
64.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.22% | ||
| 1 week | -5.25% | ||
| Current month | -6.66% | ||
| 1 month | -8.17% | ||
| 3 months | -11.87% | ||
| 6 months | -25.03% | ||
| Current year | -19.36% |
| 1 week | 22.45 |  | 23.87 |
| 1 month | 22.45 | | 24.57 |
| Current year | 22.45 | | 29.22 |
| 1 year | 22.45 | | 30.18 |
| 3 years | 20.2 | | 31.46 |
| 5 years | 17.99 | | 33.54 |
| 10 years | 12.52 | | 33.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
You Zhang Xia
CEO | Chief Executive Officer | 48 | 27/05/2019 |
Tao Mao
DFI | Director of Finance/CFO | 49 | 27/12/2023 |
Ping An Liu
PRN | Corporate Officer/Principal | 40 | 18/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ping Chen
CHM | Chairman | 64 | 15/03/2010 |
You Zhang Xia
BRD | Director/Board Member | 48 | 27/05/2019 |
Ping An Liu
BRD | Director/Board Member | 40 | 13/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.22% | -5.25% | -19.79% | -18.40% | 1.44B | |
| -1.21% | -3.04% | +44.03% | +143.07% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.15% | 550B | |
| -2.14% | -4.94% | +16.83% | +57.08% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.04% | 316B | |
| +0.61% | -1.69% | +27.35% | +13.73% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.49% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.26% | 199B | |
| -1.19% | -4.95% | +16.68% | +47.69% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.26% | 154B | |
| Average | -0.39% | -3.24% | +16.12% | +34.19% | 330.38B | |
| Weighted average by Cap. | -0.78% | -3.68% | +29.47% | +63.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.32B 638M 558M 516M 484M 903M 60.17B 910M 6.12B 2.37B 29.65B 2.39B 2.34B 103B | 4.75B 702M 614M 568M 533M 994M 66.24B 1B 6.74B 2.61B 32.64B 2.64B 2.58B 113B |
| Net income | 674M 99.58M 87.04M 80.47M 75.57M 141M 9.39B 142M 956M 370M 4.63B 374M 366M 16.06B | 745M 110M 96.21M 88.95M 83.53M 156M 10.38B 157M 1.06B 409M 5.12B 413M 404M 17.75B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 22.58 ¥ | -1.22% | 4,953,980 |
| 17/06/26 | 22.86 ¥ | -1.76% | 3,908,181 |
| 16/06/26 | 23.27 ¥ | -1.27% | 4,329,430 |
| 15/06/26 | 23.57 ¥ | -1.09% | 5,509,428 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600993 Stock
Select your edition
All financial news and data tailored to specific country editions
